Published in Int J Radiat Biol on June 22, 2011
Electron paramagnetic resonance dosimetry for a large-scale radiation incident. Health Phys (2012) 1.24
Overview of the principles and practice of biodosimetry. Radiat Environ Biophys (2014) 1.14
Assessment of biodosimetry methods for a mass-casualty radiological incident: medical response and management considerations. Health Phys (2013) 1.14
Development of a metabolomic radiation signature in urine from patients undergoing total body irradiation. Radiat Res (2014) 0.98
A review of applications of metabolomics in cancer. Metabolites (2013) 0.96
Long-term differential changes in mouse intestinal metabolomics after γ and heavy ion radiation exposure. PLoS One (2014) 0.95
Global Metabolomic Identification of Long-Term Dose-Dependent Urinary Biomarkers in Nonhuman Primates Exposed to Ionizing Radiation. Radiat Res (2015) 0.89
Exposure to ionizing radiation reveals global dose- and time-dependent changes in the urinary metabolome of rat. Metabolomics (2014) 0.88
Identification and quantitation of biomarkers for radiation-induced injury via mass spectrometry. Health Phys (2014) 0.86
Radiogenomics: A systems biology approach to understanding genetic risk factors for radiotherapy toxicity? Cancer Lett (2016) 0.85
Metabolic phenotyping reveals a lipid mediator response to ionizing radiation. J Proteome Res (2014) 0.84
Toward the development of transcriptional biodosimetry for the identification of irradiated individuals and assessment of absorbed radiation dose. Radiat Environ Biophys (2015) 0.83
Citrulline as a Biomarker in the Murine Total-Body Irradiation Model: Correlation of Circulating and Tissue Citrulline to Small Intestine Epithelial Histopathology. Health Phys (2015) 0.81
Liver metabolomics reveals increased oxidative stress and fibrogenic potential in gfrp transgenic mice in response to ionizing radiation. J Proteome Res (2014) 0.81
In vitro RABiT measurement of dose rate effects on radiation induction of micronuclei in human peripheral blood lymphocytes. Radiat Environ Biophys (2016) 0.80
Citrulline as a Biomarker in the Non-human Primate Total- and Partial-body Irradiation Models: Correlation of Circulating Citrulline to Acute and Prolonged Gastrointestinal Injury. Health Phys (2015) 0.79
Metabolomic changes in gastrointestinal tissues after whole body radiation in a murine model. Mol Biosyst (2013) 0.79
Integrative Metabolic Signatures for Hepatic Radiation Injury. PLoS One (2015) 0.79
Differential mobility spectrometry with nanospray ion source as a compact detector for small organics and inorganics. Int J Ion Mobil Spectrom (2013) 0.78
Identification of low-dose responsive metabolites in X-irradiated human B lymphoblastoid cells and fibroblasts. J Radiat Res (2014) 0.78
Metabolomic Applications in Radiation Biodosimetry: Exploring Radiation Effects Through Small Molecules. Int J Radiat Biol (2017) 0.77
Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma. BMC Genomics (2015) 0.77
Use of biomarkers for assessing radiation injury and efficacy of countermeasures. Expert Rev Mol Diagn (2015) 0.77
The ABRF Metabolomics Research Group 2013 Study: Investigation of Spiked Compound Differences in a Human Plasma Matrix. J Biomol Tech (2015) 0.76
Implications of genotypic differences in the generation of a urinary metabolomics radiation signature. Mutat Res (2016) 0.76
Rapid and High-Throughput Detection and Quantitation of Radiation Biomarkers in Human and Nonhuman Primates by Differential Mobility Spectrometry-Mass Spectrometry. J Am Soc Mass Spectrom (2016) 0.75
Modulation of Radiation Response by the Tetrahydrobiopterin Pathway. Antioxidants (Basel) (2015) 0.75
State-of-the-Art Advances in Radiation Biodosimetry for Mass Casualty Events Involving Radiation Exposure. Radiat Res (2016) 0.75
Lipidomic Signatures of Nonhuman Primates with Radiation-Induced Hematopoietic Syndrome. Sci Rep (2017) 0.75
NMR Metabolomics in Ionizing Radiation. Clin Oncol (Belmont) (2016) 0.75
Metabolomic Analysis of Mice Exposed to Gamma Radiation Reveals a Systemic Understanding of Total-Body Exposure. Radiat Res (2017) 0.75
Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (2009) 49.82
A global map of p53 transcription-factor binding sites in the human genome. Cell (2006) 20.65
HMDB: the Human Metabolome Database. Nucleic Acids Res (2007) 13.38
Cell-cycle checkpoints and cancer. Nature (2004) 13.19
A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell (2010) 12.27
Metabolomics--the link between genotypes and phenotypes. Plant Mol Biol (2002) 11.36
HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res (2008) 11.23
METLIN: a metabolite mass spectral database. Ther Drug Monit (2005) 10.15
Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol (2009) 9.67
Mass spectrometry-based metabolomics. Mass Spectrom Rev (2006) 5.23
Metabolite identification via the Madison Metabolomics Consortium Database. Nat Biotechnol (2008) 5.12
p53 and metabolism. Nat Rev Cancer (2009) 5.05
Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics (2006) 5.04
The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. Front Biosci (2008) 3.56
Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science (1996) 3.56
ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metab (2006) 3.38
GC-MS libraries for the rapid identification of metabolites in complex biological samples. FEBS Lett (2005) 3.29
DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene (2001) 3.28
Data processing for mass spectrometry-based metabolomics. J Chromatogr A (2007) 3.21
Gene Expression Dynamics Inspector (GEDI): for integrative analysis of expression profiles. Bioinformatics (2003) 2.92
Clinical applications of metabolomics in oncology: a review. Clin Cancer Res (2009) 2.91
Radiation-induced cell signaling: inside-out and outside-in. Mol Cancer Ther (2007) 2.56
Posttranslational modification of p53: cooperative integrators of function. Cold Spring Harb Perspect Biol (2009) 2.34
The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein. Trends Cell Biol (2010) 2.33
Development of gene expression signatures for practical radiation biodosimetry. Int J Radiat Oncol Biol Phys (2008) 2.28
Radiation metabolomics. 1. Identification of minimally invasive urine biomarkers for gamma-radiation exposure in mice. Radiat Res (2008) 2.27
Automated detection of inaccurate and imprecise transitions in peptide quantification by multiple reaction monitoring mass spectrometry. Clin Chem (2009) 2.14
AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncol (2010) 2.11
Chemical derivatization and mass spectral libraries in metabolic profiling by GC/MS and LC/MS/MS. J Exp Bot (2004) 2.10
Mechanism of radiation-induced bystander effects: a unifying model. J Pharm Pharmacol (2008) 2.07
Human in vivo radiation-induced biomarkers: gene expression changes in radiotherapy patients. Cancer Res (2004) 2.04
The expanding role of mass spectrometry in metabolite profiling and characterization. Chembiochem (2005) 2.04
Differential responses of stress genes to low dose-rate gamma irradiation. Mol Cancer Res (2003) 2.01
Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen. Cancer Res (2008) 2.01
Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells. Int J Radiat Oncol Biol Phys (2010) 1.89
The ATM-dependent DNA damage signaling pathway. Cold Spring Harb Symp Quant Biol (2005) 1.83
Urine metabolomics analysis for kidney cancer detection and biomarker discovery. Mol Cell Proteomics (2008) 1.78
The RABIT: a rapid automated biodosimetry tool for radiological triage. Health Phys (2010) 1.69
The biology of p38 kinase: a central role in inflammation. Curr Top Med Chem (2005) 1.67
Protein quantitation through targeted mass spectrometry: the way out of biomarker purgatory? Clin Chem (2008) 1.66
p38 MAP kinase's emerging role as a tumor suppressor. Adv Cancer Res (2004) 1.64
UPLC-ESI-TOFMS-based metabolomics and gene expression dynamics inspector self-organizing metabolomic maps as tools for understanding the cellular response to ionizing radiation. Anal Chem (2008) 1.61
Radiation metabolomics. 2. Dose- and time-dependent urinary excretion of deaminated purines and pyrimidines after sublethal gamma-radiation exposure in mice. Radiat Res (2009) 1.59
p53: 25 years after its discovery. Trends Pharmacol Sci (2004) 1.49
Ceramide-rich platforms in transmembrane signaling. FEBS Lett (2010) 1.46
Stress-specific signatures: expression profiling of p53 wild-type and -null human cells. Oncogene (2005) 1.43
Induction of stress genes by low doses of gamma rays. Radiat Res (1999) 1.41
Chemical effects in the separation process of a differential mobility/mass spectrometer system. Anal Chem (2010) 1.41
Transcription, apoptosis and p53: catch-22. Trends Genet (2005) 1.39
Metabolomics--a new exciting field within the "omics" sciences. Environ Health Perspect (2004) 1.35
Radiation-induced genomic instability and bystander effects: inter-related nontargeted effects of exposure to ionizing radiation. Oncogene (2003) 1.34
Biodosimetry on small blood volume using gene expression assay. Health Phys (2010) 1.33
Microarray analysis of p53 target gene expression patterns in the spleen and thymus in response to ionizing radiation. Cancer Biol Ther (2003) 1.32
Control of chemical effects in the separation process of a differential mobility mass spectrometer system. Eur J Mass Spectrom (Chichester, Eng) (2010) 1.31
Scrapie infectious agent is virus-like in size and susceptibility to inactivation. Nature (1984) 1.28
The mass-mobility correlation redux: the conformational landscape of anhydrous biomolecules. J Am Soc Mass Spectrom (2009) 1.28
Citrulline: a physiologic marker enabling quantitation and monitoring of epithelial radiation-induced small bowel damage. Int J Radiat Oncol Biol Phys (2003) 1.24
Selection and generation of waveforms for differential mobility spectrometry. Rev Sci Instrum (2010) 1.20
Metabolomic analysis in severe childhood pneumonia in the Gambia, West Africa: findings from a pilot study. PLoS One (2010) 1.19
The role of mass spectrometry-based metabolomics in medical countermeasures against radiation. Mass Spectrom Rev (2010) 1.13
Metabonomic variations in the drug-treated type 2 diabetes mellitus patients and healthy volunteers. J Proteome Res (2009) 1.10
Microscale LC-MS-NMR platform applied to the identification of active cyanobacterial metabolites. Anal Chem (2008) 1.08
Voluntary exploratory data submissions to the US FDA and the EMA: experience and impact. Nat Rev Drug Discov (2010) 1.08
Radiation combined injury: overview of NIAID research. Health Phys (2010) 1.03
The role of p53 in cell metabolism. Acta Pharmacol Sin (2010) 1.03
Metabonomics study of intestinal fistulas based on ultraperformance liquid chromatography coupled with Q-TOF mass spectrometry (UPLC/Q-TOF MS). J Proteome Res (2006) 1.00
Nuclear factor-kappaB (NF-kappaB) is a novel positive transcriptional regulator of the oncogenic Wip1 phosphatase. J Biol Chem (2009) 0.99
Application of a liquid extraction based sealing surface sampling probe for mass spectrometric analysis of dried blood spots and mouse whole-body thin tissue sections. Anal Chem (2009) 0.98
Xenobiotic metabolism: a view through the metabolometer. Chem Res Toxicol (2010) 0.96
Physiochemical property space distribution among human metabolites, drugs and toxins. BMC Bioinformatics (2009) 0.95
Radiobiological basis in management of accidental radiation exposure. Int J Radiat Biol (2010) 0.93
Glycolysis links p53 function with NF-kappaB signaling: impact on cancer and aging process. J Cell Physiol (2010) 0.90
The two faces of tumor suppressor p53. Am J Pathol (1996) 0.88
Toxicogenomics: overview and potential applications for the study of non-covalent DNA interacting chemicals. Mutat Res (2007) 0.84
Analysis of LC-MS data for characterizing the metabolic changes in response to radiation. J Proteome Res (2010) 0.83
Utility of separation science in metabolomic studies. J Sep Sci (2008) 0.82
Genetic toxicity assessment: employing the best science for human safety evaluation Part VII: Why not start with a single test: a transformational alternative to genotoxicity hazard and risk assessment. Toxicol Sci (2007) 0.80
Thromboxane and prostacyclin synthesis following whole body irradiation in rats. J Appl Physiol Respir Environ Exerc Physiol (1984) 0.79
Deoxycytidine in urine as an indicator of changes after irradiation. Nature (1958) 0.79
Evaluation of a differential mobility spectrometer/miniature mass spectrometer system. J Am Soc Mass Spectrom (2010) 0.79
Explorative analysis of urine by capillary electrophoresis-mass spectrometry in chronic patients with complex regional pain syndrome. J Proteome Res (2009) 0.78
Increases in 1H-NMR mobile lipids are not always associated with overt apoptosis: evidence from MG-63 human osteosarcoma three-dimensional spheroids exposed to a low dose (2 Gy) of ionizing radiation. Radiat Res (2006) 0.77
(Iso) Prostaglandins in saliva indicate oxidation injury after radioiodine therapy. Rev Esp Med Nucl (2004) 0.76
Simultaneous quantitative analysis of prostaglandins and thromboxane after low-dose X irradiation. Radiat Res (1998) 0.76
HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail (2010) 6.37
Acute heart failure syndromes: current state and framework for future research. Circulation (2005) 2.47
The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study. Eur Heart J (2009) 2.28
Protein carbonylation as a novel mechanism in redox signaling. Circ Res (2007) 2.24
Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience. Radiat Oncol (2013) 2.16
Patients with acute heart failure in the emergency department: do they all need to be admitted? J Card Fail (2012) 2.09
International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registry. Eur J Heart Fail (2015) 2.03
Hypofractionated stereotactic body radiotherapy in low-risk prostate adenocarcinoma: preliminary results of a multi-institutional phase 1 feasibility trial. Cancer (2011) 1.98
Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association. Circulation (2010) 1.84
Radical stereotactic radiosurgery with real-time tumor motion tracking in the treatment of small peripheral lung tumors. Radiat Oncol (2007) 1.70
STAT4 serine phosphorylation is critical for IL-12-induced IFN-gamma production but not for cell proliferation. Proc Natl Acad Sci U S A (2002) 1.69
AMP-activated protein kinase promotes human prostate cancer cell growth and survival. Mol Cancer Ther (2009) 1.48
The impact of radiosurgery fractionation and tumor radiobiology on the local control of brain metastases. J Neurosurg (2013) 1.48
Combinatorial synthesis of chemically diverse core-shell nanoparticles for intracellular delivery. Proc Natl Acad Sci U S A (2011) 1.46
Genomewide clonal analysis of lethal mutations in the Drosophila melanogaster eye: comparison of the X chromosome and autosomes. Genetics (2007) 1.44
A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. Eur Heart J (2008) 1.33
Radiation metabolomics. 5. Identification of urinary biomarkers of ionizing radiation exposure in nonhuman primates by mass spectrometry-based metabolomics. Radiat Res (2012) 1.29
New and emerging technologies for genetic toxicity testing. Environ Mol Mutagen (2010) 1.28
Cell signalling: cell survival and a Gadd45-factor deficiency. Nature (2003) 1.27
MetaboLyzer: a novel statistical workflow for analyzing Postprocessed LC-MS metabolomics data. Anal Chem (2013) 1.24
Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis. Anal Chim Acta (2012) 1.20
STAT3 suppresses transcription of proapoptotic genes in cancer cells with the involvement of its N-terminal domain. Proc Natl Acad Sci U S A (2013) 1.20
MicroRNA profiling in prostate cancer--the diagnostic potential of urinary miR-205 and miR-214. PLoS One (2013) 1.19
Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancer. J Hematol Oncol (2009) 1.18
Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety. Radiat Oncol (2013) 1.18
LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort. J Proteome Res (2012) 1.14
Biomarkers in the age of omics: time for a systems biology approach. OMICS (2011) 1.13
Small changes huge impact: the role of protein posttranslational modifications in cellular homeostasis and disease. J Amino Acids (2011) 1.12
CyberKnife with Tumor Tracking: An Effective Treatment for High-Risk Surgical Patients with Stage I Non-Small Cell Lung Cancer. Front Oncol (2012) 1.09
CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment. J Hematol Oncol (2010) 1.08
Predictors of regional variations in hospitalizations following emergency department visits for atrial fibrillation. Am J Cardiol (2013) 1.07
A pilot study of intensity modulated radiation therapy with hypofractionated stereotactic body radiation therapy (SBRT) boost in the treatment of intermediate- to high-risk prostate cancer. Technol Cancer Res Treat (2010) 1.07
Acute decompensated heart failure: update on new and emerging evidence and directions for future research. J Card Fail (2013) 1.04
Six-Dimensional Correction of Intra-Fractional Prostate Motion with CyberKnife Stereotactic Body Radiation Therapy. Front Oncol (2011) 1.04
Detection of Radiation-Exposure Biomarkers by Differential Mobility Prefiltered Mass Spectrometry (DMS-MS). Int J Mass Spectrom (2010) 1.04
Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer. Radiat Oncol (2013) 1.04
Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee. J Card Fail (2012) 1.02
Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee. J Card Fail (2012) 1.00
Genome-wide multi-omics profiling of colorectal cancer identifies immune determinants strongly associated with relapse. Front Genet (2013) 0.99
Low numeracy is associated with increased odds of 30-day emergency department or hospital recidivism for patients with acute heart failure. Circ Heart Fail (2012) 0.99
DNA damage signaling in hematopoietic cells: a role for Mre11 complex repair of topoisomerase lesions. Cancer Res (2008) 0.97
Emergency department observation of heart failure: preliminary analysis of safety and cost. Congest Heart Fail (2005) 0.97
Impact of diagnosis and treatment of clinically localized prostate cancer on health-related quality of life for older Americans: a population-based study. Cancer (2012) 0.97
A consensus parameter for the evaluation and management of angioedema in the emergency department. Acad Emerg Med (2014) 0.96
Detection of the acrolein-derived cyclic DNA adduct by a quantitative 32P-postlabeling/solid-phase extraction/HPLC method: blocking its artifact formation with glutathione. Anal Biochem (2007) 0.96
Small molecule metabolite extraction strategy for improving LC/MS detection of cancer cell metabolome. J Biomol Tech (2011) 0.95
Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-risk prostate cancer. J Hematol Oncol (2011) 0.94
Quantitative metabolomic and lipidomic profiling reveals aberrant amino acid metabolism in type 2 diabetes. Mol Biosyst (2012) 0.93
Gamma-tocotrienol induced apoptosis is associated with unfolded protein response in human breast cancer cells. J Nutr Biochem (2011) 0.91
iTRAQ-based quantitative protein expression profiling and MRM verification of markers in type 2 diabetes. J Proteome Res (2012) 0.91
Society of Chest Pain Centers Recommendations for the evaluation and management of the observation stay acute heart failure patient: a report from the Society of Chest Pain Centers Acute Heart Failure Committee. Crit Pathw Cardiol (2008) 0.91
CyberKnife for hilar lung tumors: report of clinical response and toxicity. J Hematol Oncol (2010) 0.91
Tumor Suppressor RARRES1 Regulates DLG2, PP2A, VCP, EB1, and Ankrd26. J Cancer (2010) 0.90
Detection of thromboxane A(2) receptor mRNA in rabbit nodose ganglion neurons. Neurosci Lett (2005) 0.89
Society of Chest Pain Centers recommendations for the evaluation and management of the observation stay acute heart failure patient-parts 1-6. Acute Card Care (2009) 0.88
Rates of emergency department visits due to pneumonia in the United States, July 2006-June 2009. Acad Emerg Med (2013) 0.87
Moving toward comprehensive acute heart failure risk assessment in the emergency department: the importance of self-care and shared decision making. JACC Heart Fail (2013) 0.87
Stereotactic body radiation therapy for liver metastases from colorectal cancer: analysis of safety, feasibility, and early outcomes. Front Oncol (2012) 0.87
Feasibility of identifying the tobacco-related global metabolome in blood by UPLC-QTOF-MS. J Proteome Res (2013) 0.86
Heart failure diagnosis in acute conditions has high agreement with inpatient diagnosis. Eur J Emerg Med (2016) 0.86
Circulating MicroRNA as Biomarkers: An Update in Prostate Cancer. Mol Cell Pharmacol (2011) 0.86
Treatment of malignant tumors of the skull base with multi-session radiosurgery. J Hematol Oncol (2009) 0.86
CD14 directs adventitial macrophage precursor recruitment: role in early abdominal aortic aneurysm formation. J Am Heart Assoc (2013) 0.86
Design and rationale of the URGENT Dyspnea study: an international, multicenter, prospective study. Am J Ther (2008) 0.85
Characterization of transgenic Gfrp knock-in mice: implications for tetrahydrobiopterin in modulation of normal tissue radiation responses. Antioxid Redox Signal (2013) 0.85
Scoring system predictive of survival for patients undergoing stereotactic body radiation therapy for liver tumors. Radiat Oncol (2012) 0.84
Modulation of fatty acid and bile acid metabolism by peroxisome proliferator-activated receptor α protects against alcoholic liver disease. Alcohol Clin Exp Res (2014) 0.84
Five fraction image-guided radiosurgery for primary and recurrent meningiomas. Front Oncol (2013) 0.84
Frameless fractionated stereotactic radiosurgery for vestibular schwannomas: a single-institution experience. Front Oncol (2013) 0.84
Adjusting for clinical covariates improves the ability of B-type natriuretic peptide to distinguish cardiac from non-cardiac dyspnoea: a sub-study of HEARD-IT. Eur J Heart Fail (2009) 0.84
Impact of congestive heart failure in patients with non-ST-segment elevation acute coronary syndromes. Am J Cardiol (2006) 0.84
Predicting survival in patients with brain metastases treated with radiosurgery using artificial neural networks. Neurosurgery (2013) 0.84
CyberKnife enhanced conventionally fractionated chemoradiation for high grade glioma in close proximity to critical structures. J Hematol Oncol (2010) 0.84
Selective paired ion contrast analysis: a novel algorithm for analyzing postprocessed LC-MS metabolomics data possessing high experimental noise. Anal Chem (2015) 0.83
Pnck induces ligand-independent EGFR degradation by probable perturbation of the Hsp90 chaperone complex. Am J Physiol Cell Physiol (2011) 0.83
Use of hydropulsion for the treatment of superficial corneal foreign bodies: 15 cases (1999-2013). J Am Vet Med Assoc (2014) 0.83
Soluble guanylate cyclase: a potential therapeutic target for heart failure. Heart Fail Rev (2013) 0.83
Stereotactic Body Radiation Therapy (SBRT) Combined With Chemotherapy for Unresected Pancreatic Adenocarcinoma. Am J Clin Oncol (2014) 0.83
Prostate specific antigen kinetics following robotic stereotactic body radiotherapy for localized prostate cancer. Acta Oncol (2014) 0.82
Evaluation of chest pain and heart failure in the emergency department: impact of multimarker strategies and B-type natriuretic peptide. Rev Cardiovasc Med (2003) 0.82
Circulatory miR-628-5p is downregulated in prostate cancer patients. Tumour Biol (2014) 0.82
Human fibroblasts for large-scale "omics" investigations of ATM gene function. Adv Exp Med Biol (2011) 0.82
A new method for alignment of LC-MALDI-TOF data. Proteome Sci (2011) 0.82
Galectin 3 complements BNP in risk stratification in acute heart failure. Biomarkers (2012) 0.82
Acoustic cardiography augments prolonged QRS duration for detecting left ventricular dysfunction. Ann Noninvasive Electrocardiol (2007) 0.82
Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association. Circulation (2017) 0.82
Disposition of emergency department patients diagnosed with acute heart failure: an international emergency medicine perspective. Eur J Emerg Med (2017) 0.79
Acoustic cardiography S3 detection use in problematic subgroups and B-type natriuretic peptide "gray zone": secondary results from the Heart failure and Audicor technology for Rapid Diagnosis and Initial Treatment Multinational Investigation. Am J Emerg Med (2010) 0.79
Initial management of patients with acute heart failure. Heart Fail Clin (2013) 0.79
Identifying radiation exposure biomarkers from mouse blood transcriptome. Int J Bioinform Res Appl (2013) 0.79
Risk stratification and short-term prognosis in acute heart failure syndromes: a review of novel biomarkers. Biomarkers (2011) 0.79
Metabolomic changes in gastrointestinal tissues after whole body radiation in a murine model. Mol Biosyst (2013) 0.79
Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer. Radiat Oncol (2013) 0.79
Detection of circulatory microRNAs in prostate cancer. Methods Mol Biol (2015) 0.79
Assessment of dyspnea early in acute heart failure: patient characteristics and response differences between likert and visual analog scales. Acad Emerg Med (2014) 0.79
Reply: BAG3 protein in advanced-stage heart failure. JACC Heart Fail (2014) 0.78
The role of the emergency department in the patient with acute heart failure. Curr Cardiol Rep (2013) 0.78
Histopathologic effects of hypofractionated robotic radiation therapy on malignant and benign prostate tissue. Technol Cancer Res Treat (2010) 0.78